In the era of personalized medicine, head and neck squamous cell carcinoma (HNSCC) represents a critical oncologic topic. Conventional chemotherapy regimens consist of drugs administration in cycles near or at the maximum tolerated dose (MDT), followed by a long drug-free period to permit the patient to recover from acute toxicities. Despite this strategy is successful in controlling the cancer process at the beginning, a significant number of HNSCC patients tend to recurred or progress, especially those patients with locally advanced or metastatic disease. The repertoire of drugs directed against tumor cells has greatly increased and metronomic chemotherapy (MC) could be an effective treatment option.It is the purpose of this article to review the concept of MC and describe its potential use in HNSCC. We provide an update of ongoing progress and current challenges related to this issue.
Head and neck cancer: metronomic chemotherapy / De Felice, Francesca; Musio, Daniela; Tombolini, Vincenzo. - In: BMC CANCER. - ISSN 1471-2407. - ELETTRONICO. - 15(2015). [10.1186/s12885-015-1705-z]
|Titolo:||Head and neck cancer: metronomic chemotherapy|
DE FELICE, FRANCESCA (Primo) (Corresponding author)
TOMBOLINI, Vincenzo (Ultimo)
|Data di pubblicazione:||2015|
|Citazione:||Head and neck cancer: metronomic chemotherapy / De Felice, Francesca; Musio, Daniela; Tombolini, Vincenzo. - In: BMC CANCER. - ISSN 1471-2407. - ELETTRONICO. - 15(2015). [10.1186/s12885-015-1705-z]|
|Appartiene alla tipologia:||01g Articolo di rassegna (Review)|